Raseel K¹* and Ramesh Sahsad PT²

¹Senior Veterinary Officer, Doha Falcon Clinic, Ainkhaled, Doha, Qatar
²Veterinary Officer, Doha Falcon Clinic, Ainkhaled, Doha, Qatar

*Corresponding Author: Raseel K, Senior Veterinary Officer, Doha Falcon Clinic, Ainkhaled, Doha, Qatar.

Received: March 07, 2022; Published: March 21, 2022

Abstract

A study was conducted for the comparative assessment and clinical evaluation of two different anti-fungal agents against aspergillosis in GYR falcons. Aspergillosis is the most common fungal infection with highest rate of mortality among birds of prey especially in falcons. GYR falons and hybrid GYR falcons are more susceptible to aspergillosis. Aspergillus genus is an opportunistic pathogen which primarily affects the avian respiratory apparatus, including lungs, air sacs and syrinx and occasionally nervous signs. 24 GYR falcons presented in Doha Falcon Clinic with symptoms like progressive emaciation, weakness, lethargy, inability to fly, poor performance in exercise and training were selected for the study and grouped in to two according to age and body weight. Diagnosis were made by radiographic examination and confirmatory diagnosis were done by endoscopy of abdominal cavity, the lungs and air sac (Coelioscopy). Itraconazole were administered at the dose rate of 15-20 mg/kg q24h for 21 days in group 1 and Voriconozole at the dose rate of 12.5 mg/kg q12h for first three days and continue q24h for 18 days in group 2 with supportive therapy. The birds were re-examined after one month for the effect and recovery of treatment. The birds treated by both therapeutic agents showed positive results and these findings indicated that Itraconazole and Voriconozole can be used against Aspergillosis in GYR falcons as primary treatment with better management practices.

Keywords: GYR Falcons; Aspergillosis; Coelioscopy; Anti-Fungal Agents

References

1. Kunkle RA and Rimler RB. “Early pulmonary lesions in turkeys produced by non-viable Aspergillus fumigatus and/or Pasteurella multocida lipopolysaccharide”. Avian Diseases 42.4 (1998): 770–780. 
2. Cooper JE. “Veterinary Aspects of Captive Birds of Prey”.2^nd edition”. Cherington, UK: Standfast Press (1985). 
3. Silvanose CD., et al. “Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole”. Veterinary Record159.9 (2006): 282-284.  
4. Phalen DN. “Respiratory medicine of cage and aviary birds”. Veterinary Clinics of North America: Exotic Animal Practice 3 (2000): 423-452.
5. Oglesbee BL. Mycotic diseases. In R.B. Altman (Edition). “Avian Medicine and Surgery 1^st edition”. Philadelphia, PA: W.B. Saunders Company (1997): 323-361.
6. Bauck L., et al. “Rhinitis: case reports. Proceedings of the Annual Conference of the Association of Avian Veterinarians”. New Orleans, USA (1997): 134.
7. Dorrestein GM. “De benauwde papegaai”. Tijdschrift voor Diergeneeskunde 117 (1992): 55-57.
8. McMillan MC and Petrak ML. “Retrospective study of aspergillosis in pet birds”. Journal of the Association of Avian Veterinarians 3 (1989): 211-215.
9. Young EA., et al. “Concomitant mycotic and verminous pneumonia in a Blue Jay from Georgia”. Journal of Wildlife Diseases 34 (1998): 625-628.
10. Abrams GA., et al. “Aspergillus blepharitis and dermatitis in a peregrine falcon-gyrfalcon hybrid (Falco peregrinus x Falco rusticolus)”. Journal of Avian Medicine and Surgery 15 (2001): 114-120.
11. Verstappen FALM and Dorrestein GM. “Aspergillosis in Amazon parrots after corticosteroid therapy for smoke-inhalation injury”. Journal of Avian Medicine and Surgery 19 (2005): 138-141.
12. Oglesbee BL. Mycotic diseases. In R.B. Altman (Edition). “Avian Medicine and Surgery 1^st edition”. Philadelphia, PA: W.B. Saunders Company (1997): 323-326.
13. Nardoni S., et al. “Aspergillosis in Larus cachinnans micaellis: survey of eight cases”. Mycopathologia 161 (2006): 317-321.
14. Tsai SS., et al. “Aspergillosis and candidiasis in psittacine and passeriform e birds with particular reference to nasal lesions”. Avian Pathology 21 (1992): 699-709.
15. Richard JL., et al. “Gliotoxin inhibits transformation and is cytotoxic to turkey peripheral blood lymphocytes”. Mycopathologia 126 (1994): 109-114.
16. Dahlhausen B., et al. “Rapid detection of pathogenic Aspergillus species in avian samples by real-time PCR assay: a preliminary report”. In E. Bergman (Edition). Proceedings of the 25^th Annual Conference and Expo of the Association of Avian Veterinarians. New Orleans, LA, USA (2004): 37.
17. Vanderheyden N. “Aspergillosis in psittacine chicks. In G. Jackson (Edition)”. Proceedings of the Annual Conference of the Association of Avian Veterinarians. Nashville, TN, USA (1993): 2077
18. Jensen HE., et al. “Immunohistochemistry for the diagnosis of aspergillosis in turkey poults”. Avian Pathology 26 (1997): 5-18.
19. Flammer K. “An overview of antifungal therapy in birds”. In G. Jackson (Edition). Proceedings of the Annual Conference of the Association of Avian Veterinarians. Nashville, TN, USA (1993): 1.
20. Di Somma A., et al. “The use of voriconazole for the treatment of aspergillosis in falcons (Falco species)”. Journal of Avian Medicine and Surgery 21 (2007): 307-316.

Citation

Citation: Raseel K and Ramesh Sahsad PT. “Assessment and Clinical implication of Aspergillosis in GYR Falcons (Falco rusticolus)”.Acta Scientific Veterinary Sciences 4.4 (2022): 75-78.

Copyright

Copyright: © 2022 Raseel K and Ramesh Sahsad PT. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.